PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.02
+0.00%Margins
Gross margin
-307.6%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-56.0%
Return on equity
-46.6%
Return on assets
-56.7%
Return on invested capital
0.00x
Asset turnover
-$7.4M
Cash from operations
$3.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026